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OBJECTIVES This study was undertaken to explore further the relationship between Doppler-derived
parameters of pulmonary flow and pulmonary vascular resistance (PVR) and to determine
whether PVR could be accurately estimated noninvasively from Doppler flow velocity
measurements in patients with chronic heart failure.
BACKGROUND The assessment of PVR is of great importance in the management of patients with heart
failure. However, because of the inconclusive and conflicting data available, Doppler
estimation of PVR is still considered unreliable.
METHODS Simultaneous Doppler echocardiographic examination and right heart catheterization were
performed in 63 consecutive sinus rhythm heart failure patients with severe left ventricular
systolic dysfunction. Hemodynamic PVR was calculated with the standard formula. The
following Doppler variables on pulmonary flow and tricuspid regurgitation velocity curve were
correlated with PVR: maximal systolic flow velocity, pre-ejection period (PEP), acceleration
time (AcT), ejection time, total systolic time (TT), velocity time integral, and right
atrium-ventricular gradient.
RESULTS At univariate analysis, all variables except maximal systolic flow velocity and velocity time
integral showed a significant, although weak, correlation with PVR. The best correlation
found was between AcT and PVR (r 5 20.68). By regression analysis, only PEP, AcT and
TT entered into the final equation, with a cumulative r 5 0.87. When the function
(PEP/AcT)/TT was correlated with PVR, the correlation coefficient further improved to
0.96. Of note, this function prospectively predicted PVR (r 5 0.94) after effective unloading
manipulations.
CONCLUSIONS The analysis of Doppler-derived pulmonary systolic flow is a reliable and accurate tool for
estimating and monitoring PVR in patients with chronic heart failure due to left ventricular
systolic dysfunction. (J Am Coll Cardiol 2001;37:1813–9) © 2001 by the American College
of Cardiology
Assessment of pulmonary vascular resistance (PVR) is of
great importance in the management of patients with
chronic heart failure, and it is an essential component of
orthotopic heart transplantation recipient evaluation. Cur-
rently, this information is obtained only with invasive
cardiac catheterization. An accurate noninvasive measure-
ment of PVR would prove helpful in eliminating the risks,
costs and discomfort associated with cardiac catheterization.
In patients with heart failure, Doppler echocardiography
has become routine in the bedside noninvasive estimation of
several hemodynamic variables (1–9). However, because of
the inconclusive and conflicting available data, Doppler
estimation of PVR is still considered unreliable (10,11).
Nevertheless, in patients with chronic heart failure, partic-
ularly those with advanced heart failure requiring serial right
heart catheterization for hemodynamic suitability for heart
transplantation, a noninvasive mode of estimating PVR
would be a highly desirable alternative.
We hypothesized a strict relationship between Doppler
systolic pulmonary flow and PVR. The present study was
undertaken to explore further the relationship between
Doppler-derived parameters of pulmonary flow and PVR
and to determine whether PVR could be accurately esti-
mated noninvasively from Doppler flow velocity measure-
ments in patients with chronic heart failure.
METHODS
Study population. This prospective study included 63
consecutive sinus rhythm patients (55 men; mean age [6
SD] 57 6 8 years) with chronic heart failure and severe left
ventricular (LV) systolic dysfunction (as defined by echo-
cardiographic ejection fraction #35%) undergoing diagnos-
tic right heart catheterization. Informed consent was ob-
tained, and the study was approved by the local Ethics
Committee at Veruno Medical Center.
Study protocol. After baseline echocardiographic evalua-
tion, patients underwent simultaneous hemodynamic and
echocardiographic examinations.
ECHOCARDIOGRAPHY. A Hewlett-Packard (Andover,
Massachusetts) Sonos 1500 ultrasound system equipped
with 2.5- and 3.5-MHz probes was used. Echocardio-
graphic studies were performed in left lateral decubitus or
supine position; all echocardiographic images were stored
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on super-VHS videotape. Left ventricular volumes were
calculated from orthogonal apical views using the biplane
area-length method. Ejection fraction was derived from the
standard equation. Both mitral and tricuspid regurgitation
were detected and graded using color flow Doppler, accord-
ing to previously reported criteria that took into account
both the width and depth of regurgitant jets in relation to
the size of the receiving chamber from multiple views (12)
and the size of the jet at the regurgitant orifice (13).
A pulsed-wave Doppler recording of pulmonary artery
flow was analyzed in a transverse parasternal view at the
level of great vessels. The sample volume was positioned in
the right ventricular outflow tract just below the pulmonary
plane. Care was taken to align the sample volume and the
axis of the bloodstream correctly to obtain the highest
possible Doppler velocity signal with the smallest amount of
spectral dispersion and to avoid possible noises due to the
Swan-Ganz catheter. Tricuspid regurgitation was detected
by continuous-wave Doppler velocity curve from apical
views. Gain and filters of the machine were adjusted to
define precisely the onset and the end of both systolic
pulmonary profile and tricuspid regurgitant velocity curve.
SIMULTANEOUS HEMODYNAMIC AND DOPPLER EXAMINA-
TION. All patients were studied in the fasting state. A 7F
Swan-Ganz catheter (Baxter Healthcare, Edwards Critical
Care Division, Deerfield, Illinois) was introduced using the
Seldinger technique through a femoral or right internal
jugular vein and positioned under fluoroscopic guidance in a
pulmonary artery. After a 10-min rest for stabilization,
pulmonary artery systolic pressure (PASP), pulmonary ar-
tery diastolic pressure (PADP) and pulmonary capillary
wedge pressure (PCWP) were obtained at end-expiration.
The wedged position of the tip of the right heart catheter
during recording of the occlusion waveform was verified
fluoroscopically. Pulmonary artery mean pressure (PAMP)
was obtained by using the standard formula:
PAMP 5 @PADP 1 1⁄3 ~PASP 2 PADP!#
Cardiac output (CO) was determined by the thermodilution
method as the mean of three consecutive measurements not
varying by .10%. The PVR, expressed in Wood units, was
calculated as:
PVR 5 ~PAMP 2 PCWP!/CO
Hemodynamic and Doppler parameters were recorded si-
multaneously. A custom-designed system connected the
echocardiographic unit to computerized hemodynamic in-
struments so that it was possible to record Doppler and
hemodynamic traces and electrocardiogram (ECG) on-line
onto both videotape and a strip chart recorder at 100 mm/s
for off-line analysis. Immediately after pulmonary systolic
flow velocity recording, continuous-wave spectral Doppler
images of the tricuspid regurgitation were recorded; there-
after, hemodynamic PAMP and PCWP were obtained. To
avoid the interference of injection of saline bolus on the
Doppler signal recording, CO was determined when Dopp-
ler measurements were completed. On the systolic pattern
of pulmonary flow, the following variables were considered:
maximal systolic flow velocity, systolic velocity time integral,
acceleration time (AcT), expressed as the time interval
between the onset of ejection to the time of peak flow
velocity, and ejection time (EjT), expressed as the time
interval between the onset and end of the systolic flow
velocity recording.
On the continuous-wave spectral Doppler velocity curve
of tricuspid regurgitation, the onset of regurgitation was
identified (Fig. 1, top) and extrapolated from the QRS
signal (used as a reference point) to the zero line on an
isorhythmic recording interval of Doppler pulmonary flow
(Fig. 1, bottom). Functional pre-ejection period (PEP) was
defined as the distance between the onset of tricuspid
regurgitation and the onset of pulmonary systolic flow. In
the presence of elevated PASP and PVR, tricuspid regur-
gitation may well continue after the premature closure of the
pulmonary valve (i.e., the premature completion of the
ejection period); thus, we calculated the total systolic time
(TT) as the summation of PEP and EjT rather than as the
total duration of tricuspid regurgitation (Fig. 1). An average
of five beats was analyzed. Finally, peak velocity on the
tricuspid regurgitation velocity curve was measured, and the
Bernoulli equation was used to calculate the right atrium-
ventricular gradient.
After completion of baseline measurements, 15 patients
with elevated PVR underwent a nitroprusside test per-
formed as follows: nitroprusside was infused at an initial
dose of 0.5 mg/kg body weight. The dose was increased by
0.5 mgzkg21zmin21 up to a maximum of 4 mgzkg21zmin21
unless the patient developed hypotension (systolic blood
pressure ,85 mm Hg), bradycardia (heart rate ,50 beats/
min), or a drop of PCWP to ,12 mm Hg. At the end of the
test, simultaneous hemodynamic and Doppler recordings
were repeated.
REPRODUCIBILITY OF NONINVASIVE DOPPLER VARIABLES.
Both intraobserver and interobserver reproducibility of
Doppler echocardiographic measurements were assessed in
Abbreviations and Acronyms
AcT 5 acceleration time
CO 5 cardiac output
ECG 5 electrocardiogram
EjT 5 ejection time
LV 5 left ventricular
PADP 5 pulmonary artery diastolic pressure
PAMP 5 pulmonary artery mean pressure
PASP 5 pulmonary artery systolic pressure
PCWP 5 pulmonary capillary wedge pressure
PEP 5 pre-ejection period
PVR 5 pulmonary vascular resistance
SD 5 standard deviation
TT 5 total systolic time
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11 consecutive patients. Measurements were repeated by the
same observer after an interval of at least one week and by
a second independent observer. The variability of the
estimated PVR was then evaluated by calculating the mean
relative difference between paired measurements and its
standard deviation (SD).
Statistical analysis. Results are given as mean 6 1 SD.
The Doppler variables were compared with the hemody-
namic PVR variables by simple linear regression analysis.
Stepwise regression analysis was also used to evaluate the
predictive power of independent variables. Noninvasive
PVR was compared with hemodynamic PVR by using linear
regression analysis and calculating the mean relative differ-
ence between paired measurements and their SD (14). A p
value ,0.05 was considered statistically significant.
RESULTS
Clinical, Doppler echocardiographic and hemodynamic
data at baseline are presented in Tables 1 and 2. All patients
had moderate to severe LV dilation and severe systolic
dysfunction (mean ejection fraction 17 6 5%). Moderate to
severe tricuspid regurgitation was detected in about 50% of
patients (severe regurgitation in 16%), whereas moderate to
severe mitral regurgitation was present in most of the
patients (90%), being severe in 32%. Mean values of PVR
and heart rate were 2.5 6 1.5 Wood units (range 0.2 to 9.2
Wood) and 80 6 14 beats/min, respectively.
Relation of Doppler echocardiographic variables to PVR.
Adequate recordings of the tricuspid regurgitation velocity
curve were obtained in 46 of the 63 study patients; record-
ings of the onset of tricuspid regurgitation and systolic
pulmonary flow patterns were obtained in all patients.
Correlations between Doppler flow velocity variables and
PVR are reported in Table 3. No correlation was found
between PVR and maximal pulmonary systolic flow veloc-
ity, and a weak correlation existed between PVR and systolic
velocity time integral (r 5 20.39), PEP (r 5 0.44) and EjT
(r 5 20.32). The AcT (r 5 20.68) and TT (r 5 20.63) on
pulmonary systolic flow pattern and right atrium-ventricular
gradient (r 5 0.58) showed the highest, although modest,
correlations with PVR. When all Doppler variables were
Figure 1. Continuous-wave Doppler recording of tricuspid regurgitant
flow (top) and pulsed-wave recording of pulmonary flow (bottom) in the
same patient. AcT 5 acceleration time; EjT 5 ejection time; PEP 5
pre-ejection period.
Table 1. Clinical and Hemodynamic Characteristics of the
Study Patients
All Patients
(n 5 63)
Mean 6 SD Range
Age (yrs) 57 6 8 37–75
Coronary artery disease (%) 35 (36%)
Heart rate (beats/min) 80 6 14 55–111
PVR (Wood) 2.5 6 1.5 0.2–9.2
CO (liter/min) 4.5 6 1.1 2.1–8
PCWP (mm Hg) 18 6 9 3–37
PAMP (mm Hg) 28 6 12 8–55
Data presented are mean values 6 SD or number of patients (%).
CO 5 cardiac output; PAMP 5 pulmonary artery mean pressure; PCWP 5
pulmonary capillary wedge pressure; PVR 5 pulmonary vascular resistance.
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analyzed in a stepwise forward regression analysis, only
AcT, PEP and TT entered into the final equation for
predicting PVR (Table 4). The most important determinant
was AcT, whereas PEP and TT provided a smaller contri-
bution. The cumulative correlation coefficient (r) was 0.87.
Based on this analysis and on pathophysiologic consid-
erations, we hypothesized that the PEP/AcT ratio, normal-
ized for TT, would represent the best mathematic function
for predicting PVR. In fact, when the function (PEP/
AcT)/TT was correlated to PVR, the correlation coefficient
(r) further improved to 0.96 (Fig. 2). The analysis led to the
following equation:
PVR 5 2 0.156 1 1.154 p @~PEP/AcT!/TT#
On Bland-Altman analysis, the mean relative difference
between measured and estimated PVR was close to 0 (0.56)
for the whole population, indicating the absence of any
systematic error.
Doppler-derived pulmonary systolic flow changes after
unloading manipulations. The effects of unloading ma-
nipulations were simultaneously evaluated by hemodynamic
and Doppler measurements in 15 patients with elevated
baseline PVR. Changes in pulmonary flow pattern variables
and PVR after nitroprusside infusion are presented in Table
5. Mean PVR decreased significantly from 4.2 6 1.3 to
2.2 6 Wood units. A significant reduction in PEP (p ,
0.05), together with a significant increase (p , 0.001) in
AcT, with no significant changes in EjT and TT of
pulmonary systolic flow, was found (Table 5). When the
reliability of the equation reported above was prospectively
tested in these patients, baseline values and changes of PVR
after unloading were still accurately predicted (Fig. 3).
Reproducibility of noninvasive estimation of PVR by
Doppler echocardiography. Both intra- and interobserver
variability for different sets of measurements of Doppler-
derived variables of pulmonary systolic flow were 5% and 4%
for maximal systolic velocity, 4.8% and 4% for velocity time
integral, 3% and 2.5% for PEP, 1.2% and 1.4% for AcT and
4% and 3.5% for EjT. Coefficients of inter- and intraob-
server variability were not statistically significant for any of
the tricuspid flow variables measured.
DISCUSSION
Doppler echocardiography provides a simple and noninva-
sive means of assessing and monitoring several hemody-
namic variables in different cardiac conditions. Evaluation of
PVR is crucial in the assessment of patients with chronic
heart failure and is of paramount importance in potential
candidates for heart transplantation. So far, however, PVR
has shown a poor correlation with Doppler variables. In this
study we demonstrated that PVR can be reliably estimated
in heart failure patients by combining Doppler echocardio-
graphic variables of pulmonary flow: the PEP/AcT ratio,
normalized for TT, allows an accurate quantitative estima-
tion of PVR. Because this relation appears linear between 0
and 9 Wood units (Fig. 2), it may be used to estimate the
absolute PVR between these values. Importantly, when the
equation was prospectively tested in the subgroup of pa-
tients with elevated PVR undergoing unloading manipula-
tions (i.e., nitroprusside infusion), the correlation still re-
mained excellent, indicating that the method can easily
allow for an identification of patients with an adverse
Table 2. Two-Dimensional and Doppler
Echocardiographic Parameters
Mean 6 SD Range
Two-dimensional data
Ejection fraction (%) 17 6 5 9–33
LVEDVI (ml/m2) 156 6 43 86–262
RVEDD (mm) 46 6 9 25–72
Right atrial area (cm2) 22 6 7 10–36
Left atrial area (cm2) 29 6 10 10–44
TR mild/moderate/severe 32/21/10
MR mild/moderate/severe 16/27/20
Doppler pulmonary flow
Vmax (cm/s) 72 6 18 35–118
VTI (s) 11.2 6 3.5 3.6–20.4
PEP (s) 0.065 6 0.025 0.019–0.133
AcT (s) 0.088 6 0.026 0.037–0.179
EjT (s) 0.247 6 0.043 0.135–0.354
TT (s) 0.312 6 0.049 0.169–0.437
(PEP/AcT)/TT 2.6 6 1.4 0.6–7.3
Tricuspid regurgitation velocity
curve
Right A-V gradient (mm Hg) 43 6 14 20–70
Data presented are mean values 6 SD or number of patients.
AcT 5 acceleration time; A-V 5 atrium-ventricular; EjT 5 ejection time;
LVEDVI 5 left ventricular end-diastolic volume index; MR 5 mitral regurgitation;
PEP 5 pre-ejection period; RVEDD 5 right ventricular end-diastolic diameter;
TR 5 tricuspid regurgitation; TT 5 total systolic time; Vmax 5 maximal systolic
velocity; VTI 5 velocity time integral.
Table 3. Correlations Between Pulmonary Doppler Variables
and Pulmonary Vascular Resistance
Correlation
Coefficient p Value
Vmax 0.16 0.38
VTI 20.39 0.02
PEP 0.44 0.002
AcT 20.68 0.0001
EjT 20.32 0.01
TT 20.63 0.01
Right A-V gradient 0.58 0.01
Abbreviations as in Table 2.
Table 4. Results of Stepwise Regression Analysis of Doppler
Indexes on Pulmonary Flow Versus Pulmonary
Vascular Resistance
Step No.
Cumulative
r Value
F Value
to Enter
No. of
Variables
Included
1. AcT 0.68* 52 1
2. PEP 0.84* 15 2
3. TT 0.87* 39 3
Final equation: PVR 5 5.8 2 31.7 p AcT 1 29.9 p PEP 2 9.9 p TT. *p , 0.0001.
Abbreviations as in Table 2.
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pulmonary vascular hemodynamic status and the determi-
nation of hemodynamic suitability for heart transplantation.
Comparison with other studies. Invasive determination of
PVR is the standard of care: PAMP minus left atrial
pressure divided by CO, expressed in Wood units, is the
well-accepted formula to calculate PVR. Although Doppler
echocardiography is an excellent methodologic alternative to
right heart catheterization, given the complexity of the
parameter to be measured, it is obvious that a single
Doppler variable would not permit a precise estimation of
PVR. Previous studies (10,11) correlating hemodynamic
variables with Doppler-derived pulmonary flow velocity
measurements in small groups of patients with a wide range
of cardiac diseases found significant correlations between
total pulmonary resistance and AcT, or AcT index (AcT/
right ventricular EjT), but the correlation with PVR was
poor. Invasive and noninvasive data sets, however, were not
acquired simultaneously, and this represents a major limi-
tation of these earlier studies.
In addition, because of the considerable scatter about the
regression line, this technique does not allow a precise
estimate of PVR, being useful only in grouping patients
with normal and elevated PVR. To overcome these limita-
tions, Stein et al. (15) recently derived PVR noninvasively
by calculating first the transpulmonary gradient as mean
PAMP minus left atrial pressure, and then dividing the
transpulmonary gradient by CO. Even in this study (Stein
et al. [15]), however, data sets were not acquired simulta-
neously, and the noninvasive technique was fairly laborious.
In our study, even with Doppler and hemodynamic data
sets simultaneously recorded, the correlation between each
single Doppler parameter and PVR was weak. In particular,
although the right atrium-ventricular gradient was strongly
related to PASP (r 5 0.92) and PAMP (r 5 0.86), its
correlation with PVR was weak (r 5 0.58). On the contrary,
a simple function (PEP/AcT)/TT derived from the Dopp-
ler pulmonary flow profile allowed for a quantitatively
reliable estimation of PVR.
Pathophysiologic considerations. Based on the well-
known correlation between Doppler pulmonary systolic flow
and pulmonary artery pressures, we hypothesized that a
reliable estimation of PVR could be possible through an
accurate analysis and interpretation of Doppler pulmonary
systolic velocity profile. As expected, we found a poor
correlation between each single Doppler variable and PVR,
whereas a stepwise regression analysis identified AcT, PEP
and TT as independent predictors of PVR. We then
elaborated further on these three variables and their relation.
As PVR increases, the right ventricle has to generate a
higher pressure to exceed the forces opposing the pulmonary
valve opening; consequently, a prolonged PEP should be
found.
Despite normal PVR, however, a prolonged PEP could
also be found in the presence of right ventricular dysfunc-
tion or intraventricular conduction disturbances. This is why
in our study the onset of PEP was not traditionally
measured on the ECG QRS peak. We instead measured
PEP as the time between the continuous-wave, Doppler-
derived onset of tricuspid regurgitation and the onset of
Doppler pulmonary systolic velocity flow, as the onset of
tricuspid regurgitation represents the very beginning of
intraventricular pressure rise, when ventricular contraction
Figure 2. Scatterplot of linear correlation between measured and Doppler-determined pulmonary vascular resistance (PVR). Vertical dashed line marks
the value of 2.6 in Doppler-determined PVR that predicts a value of 2.5 Wood in measured PVR (horizontal dashed line), above which PVR is commonly
considered to be increased. AcT 5 acceleration time; PEP 5 pre-ejection period; TT 5 total systolic time, all of them on Doppler pulmonary flow.
Table 5. Hemodynamic Pulmonary Vascular Resistance and
Pulmonary Doppler Variables at Baseline and After
Nitroprusside Infusion
Baseline Nitroprusside Infusion
PVR (Wood) 4.2 6 1.3 2.2 6 1.1
Vmax (cm/s) 84 6 18 86 6 26
VTI (s) 9.3 6 2.4 11.2 6 2.2
PEP (s) 0.084 6 0.030 0.064 6 0.019*
AcT (s) 0.075 6 0.022 0.093 6 0.019†
EjT (s) 0.221 6 0.061 0.240 6 0.039
TT (s) 0.306 6 0.082 0.303 6 0.032
*p , 0.05. †p , 0.001.
Abbreviations as in Tables 1 and 2.
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becomes effective and consequently able to generate the flow
through the pulmonary valve.
Furthermore, in the presence of elevated PVR, after
pulmonary valve opening, right ventricular pressure will
rapidly equalize pulmonary artery pressure. As a conse-
quence, a shorter AcT, together with a shorter EjT, should
be expected. In light of these considerations, we hypothe-
sized that the ratio between these different times would
better express the pathophysiologic relation between Dopp-
ler variables and PVR. Indeed, the PEP/AcT ratio, normal-
ized for TT, showed the strongest relation to PVR (r 5
0.96).
Study limitations. The major limitation of this study could
be the need to perform measurements in two different sets
of Doppler recordings—that is, during tricuspid regurgita-
tion and during systolic pulmonary flow, to measure PEP; it
should also be noted, however, that the hemodynamic
assessment of PVR requires three separate data set record-
ings (i.e., PAMP, PCWP, CO). The accurate selection of
iso-rhythmic cycles to avoid possible mistakes in PEP
evaluation is crucial. In this view, patients with atrial
fibrillation were excluded, although theoretically it should
not pose any absolute limitation if more cardiac cycles are
averaged. Further studies are warranted not only in this
subset of patients but also in other patient groups—those
with primary pulmonary vascular disease and those with
normal ejection fractions.
Invasive CO was obtained by the thermodilution method.
Although the Fick equation should be recommended when
assessing CO in patients with heart failure, particularly
when severe tricuspid regurgitation is present, thermodilu-
tion is typically what is performed clinically.
In our study population of heart failure patients, at least
mild tricuspid regurgitation was present. The presence of
trivial tricuspid regurgitation could affect the recording of
the continuous-wave Doppler profile of the regurgitant flow
for PEP estimation, but it should be emphasized that only
the very onset of tricuspid regurgitation is required, usually
easy to obtain even in trivial insufficiency.
Conclusions. Our study provides evidence that the analysis
of Doppler-derived pulmonary systolic flow is a reliable tool
for estimating and monitoring PVR in patients with chronic
heart failure. This noninvasive methodology may constitute
an alternative to routine right heart catheterization in
potential heart transplantation candidates and could help
physicians in the safe and cost-effective bedside manage-
ment of patients with congestive heart failure.
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